Nearly 500 million people in the world suffer from diabetes, mainly type 2 diabetes, and this number is expected to soar in the next few years. Diabetes is also associated […]
On Oct. 18, 2017, the Food and Drug Administration (FDA)’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has unanimously voted 16-0 to support the approval of Novo Nordisk’s semaglutide, a […]
Diabetes mellitus (DM), commonly referred to as diabetes, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar) levels over a prolonged period, either […]